Clearside Biomedical
(NASDAQ) CLSD
Clearside Biomedical Financials at a Glance
Market Cap
N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$3.33M
Net Income (TTM)
-$26.00M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Estimated Earnings Date
May 12, 2026
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Estimated Earnings Date
May 12, 2026
CLSD News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Clearside Biomedical
Industry
Pharmaceuticals
Sector
Health CareEmployees
32
CEO
George M. Lasezkay, PharmD
Website
www.clearsidebio.comHeadquarters
Alpharetta, GA 30005, US
CLSD Financials
Key Financial Metrics (TTM)
Gross Margin
89.02%
Operating Margin
-523.09%
Net Income Margin
-618.26%
Return on Equity
37.73%
Return on Capital
-212.13%
Return on Assets
-160.55%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$2.85M
Operating Income
-$22.96M
EBITDA
-$14.37M
Operating Cash Flow
-$21.29M
Capital Expenditure
-$453.00K
Free Cash Flow
-$21.74M
Cash & ST Invst.
$6.80M
Total Debt
$446.00K
Clearside Biomedical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$201.00K
-80.6%
Gross Profit
$201.00K
-80.6%
Gross Margin
100.00%
N/A
Market Cap
N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
N/A
N/A
Employees
32
N/A
Net Income
-$5.97M
+22.3%
EBITDA
-$3.32M
+35.6%
Quarterly Fundamentals
Total Cash
$6.80M
-71.2%
Total Debt
$446.00K
-99.1%
Accounts Receivable
$266.00K
-66.2%
Inventory
$0.00
N/A
Long Term Debt
$62.00K
-99.9%
Short Term Debt
$384.00K
+2.9%
Return on Assets
-1.61%
N/A
Return on Invested Capital
-1.78%
N/A
Free Cash Flow
-$5.48M
+8.1%
Operating Cash Flow
-$5.48M
+7.3%